Fetal membranes (amnion and chorion) have recently raised significant attention as potential sources of stem cells. We have recently demonstrated that cells derived from human term placenta show stem cell phenotype, high plasticity, and display low immunogenicity both in vitro and in vivo. Moreover, placenta-derived cells, after xenotransplantation, are able to engraft in solid organs including the lung. On these bases, we studied the effects of fetal membrane-derived cells on a mouse model of bleomycin-induced lung fibrosis. Fetal membrane-derived cells were infused 15 min after intratracheal bleomycin instillation. Different delivery routes were used: intraperitoneal or intratracheal for both xenogeneic and allogeneic cells, and intravenous for allogeneic cells. The effects of the transplanted cells on bleomycin-induced inflammatory and fibrotic processes were then scored and compared between transplanted and control animals at different time points. By PCR and immunohistochemistry analyses, we demonstrated the presence of transplanted cells 3, 7, 9, and 14 days after transplantation. Concomitantly, we observed a clear decrease in neutrophil infiltration and a significant reduction in the severity of bleomycin-induced lung fibrosis in mice treated with placenta-derived cells, irrespective of the source (allogeneic or xenogeneic) or delivery route. Our findings constitute further evidence in support of the hypothesis that placenta-derived cells could be useful for clinical application, and warrant further studies toward the use of these cells for the repair of tissue damage associated with inflammatory and fibrotic degeneration. 405 406 CARGNONI ET AL.
INTRODUCTION
A number of studies performed in experimental models have shown that cell therapy may represent a promising approach for treatment of lung fibrotic diseases, Pulmonary fibrosis is characterized by excessive deposition of extracellular matrix in lung parenchyma, although conflicting results have been reported by different groups to date (9). leading to progressive remodeling of pulmonary tissue and loss of normal architecture and, eventually, to organ On the one hand, a number of authors have demonstrated that bone marrow-derived cells (12,23) and stem failure. Fibrosis is a typical component of many interstitial lung diseases, including idiopathic pulmonary fibro-cells isolated from cord blood (40) are able to engraft in mouse lungs and differentiate, in vivo, into alveolar sis (IPF), which is the most frequent in humans, as well as fibrotic diseases caused by tuberculosis, connective epithelial cells, and result in repair of various forms of lung damage (17, 33, 44) . On the other hand, some stud-tissue disorders, or exposure to chemical agents, inorganic fibers, radiation, or pathogens (35, 43) .
ies have suggested that both unfractionated bone marrow cells or purified hematopoietic stem cells are not able to Despite extensive research aimed at understanding the molecular mechanisms involved in fibrogenesis, no reconstitute lung epithelium (4,20) but can instead act as a potential source of fibroblasts, which play an active therapy has yet been able to effectively reverse or stop progression of the fibrotic process.
role in the lung fibrotic process (9, 16 ).
In addition, transplantation of stromal bone marrow Forensic Medicine, University of Turin) were used to obtain allogeneic fetal membrane-derived cells. cells (21) and stem cells isolated from amniotic fluid (3) have been shown to result in engraftment of cells with
All animal experiments were carried out in accordance with current Italian and European regulations and morphology and phenotype of epithelial lung lineages in recipient animals with injured lung parenchyma. More laws on the Use and Care of Animals for research (DL. 116/27 January 1992). recently, transplantation of allogeneic mesenchymal stem cells has resulted in reduction of fibrosis in the Each C57BL/6 mouse was weighed before any type of treatment was performed, and also before euthanasia. lungs of mice treated with bleomycin (30) , with this effect most likely to be due to blocking of IL-1 and TNF-C57BL/6 mice were randomly divided into four main treatment groups: Saline control group-mice intratra-α production by macrophages (29) . Finally, transplantation of syngeneic alveolar type II epithelial cells (36) cheally instilled with saline, euthanized after 14 days; Cell control group-mice receiving allogeneic or xeno-into bleomycin-treated rodents has been shown to result in a marked reduction in lung inflammation and fibrosis.
geneic cell transplants and euthanized 3, 7, 9, and 14 days after cell transplantation; Bleomycin-treated group-Recently, we have demonstrated that amniotic and chorionic cells from human term placenta show a stem mice intratracheally instilled with bleomycin and euthanized after 3, 7, 9, and 14 days; Bleomycin + cell-treated cell phenotype and functional potential (32) . In particular, human amniotic epithelial cells (hAEC) express em-group-mice intratracheally instilled with bleomycin and transplanted with allogeneic or xenogeneic cells and bryonic cell markers and are capable of differentiation toward tissues of all three germ layers (19, 28, 41) . Mean-euthanized after 3, 7, 9, and 14 days. while, human amniotic mesenchymal stromal cells Induction of Lung Injury With Bleomycin (hAMSC), like mesenchymal stromal cells of other origins, have the capacity to differentiate toward cells of C57BL/6 mice were anesthetized by intraperitoneal injection of xylazine (2 mg/kg) and ketamine (100 mg/ the mesodermal lineages (38). In addition, these cells display low immunogenicity both in vitro (25) and in kg). The trachea was exposed and 50 µl of bleomycin (4 U/kg) were slowly instilled into the tracheal lumen vivo (1) and are able, after xenotransplantation, to engraft in solid organs including the lung (1). The potential (31) . Control mice received the same volume of sterile saline. Intratracheal instillation was performed during a application of fetal membrane-derived cells as a therapeutic tool for disorders characterized by inflammation deep inspiration after compression of the thorax, in order to aid distribution of bleomycin to distal airspaces. and fibrosis is supported by previous studies, which report that when applied in the treatment of skin and ocu-Human Fetal Membrane-Derived Cell Preparation lar disorders (5, 22, 27, 39) , amniotic membrane results in downregulation of fibrotic and inflammatory responses Human term placentas were obtained with maternal consent according to the guidelines of the Ethical Com-[reviewed in (8)].
Here, we set out to evaluate the effects of fetal mem-mittee of the Catholic Hospital (CEIOC), and were immediately processed as previously described (1) . Briefly, brane-derived cell transplantation in bleomycin-treated mice, which represent a widely accepted model of lung the amnion and chorion were manually separated and washed in phosphate-buffered saline (Sigma-Aldrich, St interstitial fibrosis (2,7,11). We observed that intratracheal and intraperitoneal transplantation of either alloge-Louis, MO, USA) containing 100 U/ml penicillin and 100 µg/ml streptomycin (Lonza, Basel, Switzerland). neic or xenogeneic fetal membrane-derived cells can result in a reduction in bleomycin-induced lung fibrosis.
Amnion fragments (ϳ2 × 2 cm) were enzymatically digested with 2.4 U/ml dispase (Becton Dickinson, NJ, These findings provide evidence that fetal membranederived cells may prove useful for cell therapy of fi-USA) for 9 min at 37°C, followed by a second digestion with 0.75 mg/ml collagenase (Roche, Mannheim, Ger-brotic diseases in the future. many) and 20 µg/ml DNAse (Roche, Mannheim, Germany) for 150 min at 37°C. Chorion fragments were MATERIALS AND METHODS subjected to two 9-min dispase digestions, separated by Animals and Experimental Groups one 9-min wash step in RPMI-1640 (Lonza, Basel, Switzerland) containing 100 U/ml penicillin, 100 µg/ml Experiments were carried out in a total of 197, 8-9-week-old female C57BL/6 mice (Charles River, Italy), streptomycin, and 10% heat-inactivated FBS (Sigma-Aldrich, USA). The chorionic stromal layer was then which have previously been reported to be bleomycin sensitive (10,15). Placentas from female BALB/c (Charles separated from the trophoblastic layer and digested with collagenase and DNAse for 120 min at 37°C. After gen-River, Italy) and BCF1 green fluorescent protein (GFP)expressing mice (kindly provided by Dr. Alessandro tle centrifugation (150 × g for 3 min), the supernatant containing amniotic and chorionic mesenchymal stromal Vercelli, Department of Anatomy, Pharmacology and cells (hAMSCs and hCMSC) was filtered through a 100-volume of 200 µl for intraperitoneal delivery, or 100 µl for intrajugular or intratracheal delivery. µm cell strainer (Becton Dickinson, NJ, USA). The collagenase-undigested amnion fragments were further Sample Collection incubated with 0.25% trypsin for 2 min at 37°C (Sigma-After euthanasia, lungs were removed, sectioned, and Aldrich, USA) to isolate amniotic epithelial cells formalin fixed for microscopy analysis, or frozen at (hAECs).
−80°C for PCR analysis. The fetal membrane-derived cellular fractions (hAMSCs, hCMSCs, and hAECs) were cryopreserved Histological Evaluation of Lung Injury separately in 10% DMSO supplemented with 90% FBS Formalin-fixed (10% neutral formalin, Bio-Optica, until use in cell transplantation procedures.
Milano, Italy) lung tissues were embedded in paraffin.
Murine Fetal Membrane-Derived Cell Preparation
Serial sections 4 µm in thickness were cut and stained with hematoxylin and eosin and Masson's trichrome to Placentas were harvested from pregnant BALB/c and identify inflammatory cells, fibroblasts, and collagen de-GFP + BCF1 mice, at gestation day 16-18, and immediposition. Two to four sections for each lung sample and ately processed, without separation of the amniotic and for each stain were analyzed. chorionic membranes, through sequential enzymatic di-Histological grading of inflammation and fibrosis gestions similar to those applied for the isolation of cells was performed by a pathologist using a blinded semifrom human placenta. Briefly, placentas were digested quantitative scoring system adapted from Hagood et al. at 37°C with 2.4 U/ml dispase for 5 min, followed by (14) . Specifically, inflammation severity was evaluated incubation with 0.75 mg/ml collagenase and 20 µg/ml based on the presence of macrophages, neutrophils, and DNAse for 90 min at 37°C. After a gentle centrifugation lymphocytes and of edema. Subjective scores from 0 to step (150 × g for 3 min) and filtration through a 100-µm 3 were given to reflect absent, mild, moderate, or extencell strainer, a mix of amniotic and chorionic cells was sive cell infiltration. Similarly, scores from 0 to 3 were obtained. The collagenase-undigested fragments were assigned for edema intensity, which indicates the presthen further incubated with 0.25% trypsin for 2 min at ence of luminal proteinaceous material. The sum of the 37°C in order to detach fetal membrane-derived epithescores reflecting cell infiltration and edema intensity lial cells. Each murine placenta yielded around 1 × 10 6 was used to define the "severity of the inflammation." cells.
The "extent of inflammation" was indicated as the per-Transplantation of Fetal Membrane-Derived Cells centage of the examined area (two to four entire sections for each sample) that was affected by inflammatory pro-Xenogeneic fetal membrane cells derived from cesses. Examined sections were assigned to four perhuman term placenta were transplanted as a mixture centage groups: 0-25%, 25-50%, 50-75%, or >75%. composed of approximately 50% mesenchymal cells
The fibrotic process was evaluated based on the pres-(hAMSCs + hCMSCs) and 50% epithelial cells (hAECs). ence of fibroblasts and collagen deposition. Subjective Allogeneic fetal membrane cells derived from mouse scores from 0 to 3 were given to reflect absence, mild, placenta were used as a total fraction due to the impossimoderate, or extensive cell infiltration. Similarly, scores bility of separating the amniotic and chorionic memfrom 0 to 3 were assigned for collagen deposition evalubranes in mice. ated by Masson's staining. By adding the scores relative Cryopreserved human and murine cells were thawed to fibroblast infiltration and collagen deposition, we deand their vitality was checked by trypan blue exclusion termined the "severity of fibrosis." The "extent of fibroimmediately before transplantation. In all cases, at least sis" was represented as the percentage of the examined 85% of the transplanted cells were viable. area, which was affected by the fibrotic process as re-Cell transplantation was performed both in control ported above for the assessment of the inflammation mice (Cell control group) and in mice that had been process. treated with bleomycin 15 min before cell administration (Bleomycin + Cell-treated group).
Detection of Allogeneic and Xenogeneic Fetal Transplantation was performed under anesthesia via
Membrane-Derived Cells in Host Lungs three different routes, namely intrajugular and intraperitoneal (systemic deliveries), or intratracheal (local de-PCR Analysis. Total DNA (50-100 ng) was extracted from lung tissue using a Bio robot EZ1 (Qiagen, livery).
Mice received either 4 × 10 6 cells for intraperitoneal Hilden, Germany) and the EZ1 Tissue Kit (Qiagen) according to the manufacturer's instructions, and was then transplantation, or 1 × 10 6 cells for intrajugular or intratracheal transplantation. Cells were resuspended in se-amplified in 50-µl reactions containing dNTPs (200 µmol) and GoTaq DNA polymerase reagents (Promega, rum and phenol red-free DMEM and injected in a final Madison, WI, USA) and the following primers (25 RESULTS pmol) specific for the human sequence of the cyto-
Effect of Different Treatments on Body Weight chrome B mitochondrial gene: 5′-CCCATACATTGG
Mice used in this study had a baseline body weight of GACAGACC-3′ (forward) and 5′-GACGGATCGGA 18.7 ± 0.1 g. After 14 days, the weight of control mice GAATTGTGT-3′ (reverse) (37); GFP sequence was deincreased to 21.0 ± 0.2 g (n = 11). Animals transplanted tected using a primer pair that we designed: 5′-AC with allogeneic and xenogeneic fetal membrane-derived GACGGCAACTACAAGACC-3′ (forward) and 5′-GT cells, without bleomycin instillation, showed similar CCTCCTTGAAGTCGATGC-3′ (reverse).
body weight increases to control mice, while the weight All PCR reactions included an initial step at 95°C for of bleomycin-treated mice decreased significantly to 10 min. This was followed by 40 cycles (94°C for 30 s, 17.5 ± 0.8 g (n = 19) (p < 0.05). Bleomycin-treated mice 58°C for 30 s, 72°C for 1 min) for DNA amplification that received cell transplants showed a less dramatic deof human mitochondrial cytochrome B, or 45 cycles cline in body weight and in some cases an increase in (94°C for 1 min, 58°C for 30 s, 72°C for 1 min) for body weight was observed, as reported in Table 1 . GFP. PCR products were analyzed by agarose gel electrophoresis and ethidium bromide staining, followed by Bleomycin-Induced Lung Injury Southern blotting. For Southern blot analysis, PCR products were transferred to nylon membranes (Hybond N+, As expected (30) , intratracheal instillation of bleomycin resulted in marked lung injury. Progression of lung Amersham Biosciences, Little Chalfont, UK) and hybridized to specific probes labeled with horseradish per-inflammation and fibrosis are shown in Figures 1A and B, respectively, through representative photomicro-oxidase enzyme (ECL Gold, Amersham Biosciences). Chemiluminescent signals were detected with a Gel Doc graphs of lung histopathological analyses performed at different time points (3, 7, and 14 days) after bleomycin 2000 system (Bio-Rad, Hercules, CA). treatment. Immunohistochemistry. Immunohistochemical stud-Intratracheal instillation of bleomycin resulted in proies were performed on formalin-fixed and paraffingressive and marked infiltration of inflammatory cells in embedded tissue sections using the Vector M.O.M. lung interstitial and intra-alveolar spaces (Fig. 1A , a1-Immunodetection kit (Vector, Burlingame, CA). To de-a3), which was associated with a progressive and extect the presence of human cells, samples were immunotensive thickening of the interalveolar septa ( Fig. 1A , stained with a monoclonal antibody specific for cytoker-a1-a2). Inflammatory cell infiltration, together with fiatin 19 (CK 19, Ab-4) (clone BA17, LabVision, broblast accumulation and marked collagen deposition Fremont, CA) diluted 1:50.
in the interstitial spaces, as revealed by Masson's stain-Allogeneic GFP + cells were detected using a monoing ( Fig. 1B , b1-b3), led to almost complete obliteration clonal anti-GFP antibody (clone GFP01, LabVision, of the alveolar spaces (Figs. 1A and B, a3 and b3). Fremont, CA) diluted 1:300. Before staining, sections 4
In order to quantify the effect of bleomycin treatment µm thick were deparaffinized and unmasked with Wand the efficacy of placenta-derived cell transplantation, CAP citrate buffer pH 6 (Bio-Optica, Milan, Italy). The we scored severity and extent of inflammation and fibroendogenous peroxidase activity was blocked using 3% sis in at least four different lung samples obtained from hydrogen peroxide solution.
each analyzed animal. The severity of inflammation was The primary antibody was then applied for 1 h at calculated by summing the scores representing the level room temperature. Novared (Vector) was used as the of infiltration by each inflammatory cell population. Figchromogen , and hematoxylin for counterstaining. Photoure 1A shows the correspondence between cell infiltragraphs were taken with an Olympus BX41 microscope tion and assigned score (panels M1-M3 for macrousing 40× and 20× lenses using an Olympus SP-500UZ phages; panels N1-N3 for neutrophils; panels L1-L3 Camera.
for lymphocytes). The correspondence between fibroblast infiltration and collagen deposition (parameters Statistical Analysis used to define the severity of lung fibrosis) and the attributed scores are shown in Figure 1B area presenting with signs of these two processes with plants again showed a nonsignificant difference in lung inflammation compared to mice treated with bleomycin respect to the total area examined, are shown on the right y-axis (gray bars) (Fig. 2) . alone (4.50 ± 1.17 vs 5.76 ± 0.47 score units, respectively) (Fig. 3A) . Interestingly, however, significant re-Intratracheal saline injection produced only slight inflammation (Fig. 2) , likely due to local trauma, while ductions in both severity (2.08 ± 0.71 vs. 4.11 ± 0.39 score units; p < 0.05) and extent (18.75 ± 7.00% vs. no signs of fibrosis were observed (Fig. 2) . Bleomycintreated animals showed early development of inflamma-46.05 ± 5.75% lung area involved; p < 0.05) of lung fibrosis were observed in samples from bleomycin-treated tion, which at day 3 involved about 25% of the total lung area examined. The inflammatory process contin-mice that received cell transplants (Fig. 3B) .
To study the effect of another allogeneic cell source ued to progress with time in the lungs of these animals, reaching its maximum levels in terms of severity (5.35 ± and different transplantation routes, we transplanted bleomycin-treated C57BL/6 mice with allogeneic BCF1, 0.39 score units) and extent (50-75% of lung areas) by day 9 after bleomycin instillation (Fig. 2) .
GFP + murine fetal membrane-derived cells. Cell delivery in this case was performed by intraperitoneal and Fibrosis was detected at day 7 after bleomycin treatment (Fig. 2) , and progressively increased over the study intratracheal injections. Irrespective of the delivery route, allogeneic BCF1 period. By day 14, the severity of fibrosis had reached its maximum levels with an involvement of 50-75% of cell transplantation did not change lung inflammation and fibrosis at days 3 and 7 after bleomycin instillation examined lung areas (Fig. 2) .
(data not shown).
Allogeneic Transplantation of Fetal
At days 9 and 14, mice treated with bleomycin and Membrane-Derived Cells allogeneic cells (administered either intraperitoneally or intratracheally) showed similar levels of inflammation Bleomycin-treated C57BL/6 mice were transplanted via the intrajugular route with cells isolated from the to those observed in bleomycin-instilled mice that did not receive cell transplantation ( Fig. 4A and B ). allogeneic fetal membranes (amnion and chorion) of BALB/c placentas obtained at gestation day 16-18. However, similarly to what was observed in animals transplanted with BALB/c fetal membrane-derived cells, At day 9, mice that had been treated with both bleomycin and allogeneic cells showed a reduction, although transplantation of BCF1 placenta cells caused a reduction in bleomycin-induced lung fibrosis at day 14, both not significant, in the severity of lung inflammation (4.14 ± 0.55 score units) with respect to bleomycin-after intraperitoneal or intratracheal cell delivery (from 4.11 ± 0.39 to 2.69 ± 0.34 and to 1.50 ± 0.49 score units, treated mice (5.35 ± 0.39 score units). The extent of inflammation between these two groups did not differ sig-respectively; p < 0.05 and p < 0.01) (Fig. 4D ). After intratracheal cell delivery, a significant decrease in the ex-nificantly and, furthermore, no differences were observed in severity and extent of fibrosis (data not shown). At tent of fibrosis was also observed (from 46.05 ± 5.75% to 17.75 ± 5.25% lung area involved; p < 0.05) (Fig. 4D ). day 14, bleomycin-treated mice that received cell trans- Allogeneic transplantation into bleomycin-untreated geneic fetal membrane cells derived from human term placenta. mice caused an inflammatory response that was still present 9 days after both intraperitoneal and intratra-Three and 7 days after intraperitoneal or intratracheal transplantation with human fetal membrane-derived cells, cheal cell delivery (Fig. 4A ). This inflammation was no longer observed at day 14 after intraperitoneal allotrans-lungs from bleomycin-treated mice showed inflammation and fibrosis similar to mice that had received no plantation, while it persisted, albeit with lower severity and extent, in intratracheally cell transplanted animals cell treatment (data not shown). At days 9 and 14 we continued to observe nonsignifi- (Fig. 4B ). No signs of lung fibrosis were observed in any animals treated with cells alone (Fig. 4C and D) .
cant changes in the severity of bleomycin-induced lung inflammation in cell transplanted mice compared to non-
Transplantation of Xenogeneic Fetal Membrane Cells
transplanted mice (Fig. 5B) . Interestingly, fetal mem-Derived From Human Term Placenta brane-derived cell xenotransplantation did not result in significant changes in either severity or extent of bleo-The same transplantation settings used for allogeneic BCF1 cell transplantation were also applied using xeno-mycin-induced fibrosis at day 9 (Fig. 5C) ; however, by day 14, severity of bleomycin-induced fibrosis was sig-significant changes in the extent of bleomycin-induced fibrosis regardless of the days after treatment or the nificantly reduced in xenotransplanted mice (from 4.11 ± 0.39 in nontransplanted mice to 2.38 ± 0.40 and 2.50 ± route of transplantation (Figs. 5C and D). As also observed for allotransplantation, xenotrans-0.31 score units after intraperitoneal and intratracheal cell injections, respectively; p < 0.01 and p < 0.05) ( Fig. plantation of cells into bleomycin-untreated mice caused an inflammatory response that was still present at day 14 5D). Representative examples of the reduction in collagen deposition, which was observed at day 14 after in-after both intraperitoneal and intratracheal cell delivery ( Figs. 5A and B ). As seen after allogeneic transplanta-traperitoneal xenogeneic placenta cell transplantation, are shown in Figure 6A . tion, xenogeneic transplantation alone did not induce lung fibrosis (Figs. 5C and D) . Xenogeneic cell transplantation did not cause any 
Effect of Fetal Membrane-Derived Cell
percentage of analyzed sections that showed these different degrees of infiltration for each cell type, with the Transplantation on the Presence of Specific Inflammatory Cell Types total number of sections examined reported. Saline-treated mice showed a very slight inflammatory response, with low levels of macrophages and neu-The inflammation score gives a comprehensive indication as to the severity of inflammation. In attempting trophils observed in 13.6% and 18.2% of examined sections, respectively, and absence of lymphocytes. to understand whether the different treatments could affect the relative involvement of each cell type (i.e., mac-In the lungs of bleomycin-treated mice, macrophages and lymphocytes could be detected as early as 3 days rophages, neutrophils, and lymphocytes) in the inflammatory process, we evaluated the level of infiltration of after bleomycin instillation. At this time point, macrophages were present at low or moderate levels in all each of these cell types in all lung sections examined for each treatment group and time point. By microscopy examined sections, while lymphocytes were observed in only 16.7% of the sections examined, and only at low analysis, we counted the lung sections that showed no infiltration (level 0), low infiltration (level 1), moderate levels. Neutrophil infiltration began later, and was detected at day 7 after bleomycin instillation. Infiltration infiltration (level 2), or marked infiltration (level 3) for each cell type, and expressed the numbers of sections of macrophages and lymphocytes increased progressively and massively, as demonstrated by an increase in showing these varying levels of infiltration as a percentage of the total number of sections examined for each the number of lung sections from bleomycin-treated mice, which showed level 3 infiltration over the course treatment group and time point. Table 2 of this study. On the contrary, at day 14 neutrophils while neutrophils were absent in bleomycin-treated mice that had been intratracheally transplanted with alloge-were absent in 60% of the sections analyzed, or were present at low or moderate levels (Table 2) . neic cells. Only a low proportion of sections were found to be positive for neutrophils in mice that had been intra-Allogeneic intratracheal cell transplantation and xenogeneic intraperitoneal and intratracheal cell transplan-peritoneally transplanted with allogeneic (6.2%, at level 2) and xenogeneic cells (3.1%, at level 1). tation all resulted in mild lung infiltration (level 1) by all three cell types, with sporadic presence of macro-Representative photomicrographs demonstrating reduced lung infiltration by neutrophils at day 14 after in-phages and lymphocytes at moderate levels also observed at days 3 and 7.
summarizes the
traperitoneal xenogeneic placenta cell transplantation are shown in Figure 6B . After intraperitoneal and intratracheal cell transplantation of either allogeneic or xenogeneic cells, we de-
Assessment of Allogeneic and Xenogeneic Fetal tected lower proportions of infiltrating macrophages in
Membrane-Derived Cells in Host Lungs lung sections from bleomycin-instilled mice compared to mice treated with bleomycin only, and this difference As reported in Figure 7A , PCR analysis was performed to investigate the presence of allogeneic (BCF1 was particularly evident at early time points. Lymphocyte infiltration did not show notable differences be-GFP + ) and xenogeneic (human) DNA in the lungs of transplanted mice. GFP or human DNA was detectable tween bleomycin-instilled, cell-treated mice compared to mice treated only with bleomycin. Interestingly, at until day 14 in the lungs of mice that had received intratracheal or intraperitoneal cell transplants (Fig. 7A) . The day 14, with the exception of sections from intratracheally xenotransplanted mice, all other conditions of stronger intensity of the human signal versus the GFP signal is very likely due to the fact that the system used cell source (xeno-or allogeneic) and delivery route (intraperitoneal and intratracheal) showed an evident re-to detect human DNA is based on PCR amplification of a mitochondrial DNA sequence, which is present at duction in neutrophil infiltration when compared to bleomycin-treated mice. Indeed, neutrophil infiltration higher copy number with respect to the genomic GFP DNA sequence (37) . was detected in 40% of the examined sections from bleomycin-treated mice at day 14 the jugular vein upon injection, we used intraperitoneal transplantation as an alternative systemic delivery route tion, and at 3 and 14 days after intraperitoneal injection are shown in Figure 7B . The presence of human cells in for these cells, also based on our previous results showing that amniochorionic cells are able to migrate to the mouse lungs, as shown by positive staining for antihuman CK 19, was observed at days 3 and 14 after xe-lung, as well as other organs, after intraperitoneal xenotransplantation (1). nogeneic intratracheal and intraperitoneal transplantation (Fig. 7B) .
Our results show that, regardless of the route of inoculation and the cell source (allogeneic or xenogeneic), DISCUSSION transplantation of fetal membrane-derived cells resulted in a significant antifibrotic effect in bleomycin-treated In this study we have demonstrated that both allogeneic and xenogeneic transplantation of fetal membrane-animals. Interestingly, preliminary results from additional studies that we conducted by applying intrapulmo-derived cells can reduce bleomycin-induced lung fibrosis in C57BL/6 mice. nary cell injection also yielded similar results (data not shown). Even though cell therapy-based treatments for lung fibrosis have shown conflicting results to date regarding Based on previous reports showing that maximum lung fibrosis and eventual resolution is observed by day the ability of bone marrow-derived cells to differentiate into pneumocytes (9), decreased lung fibrosis has been 14 in bleomycin lung-injured mice, a 14-day transplantation model was also used in this study. Over this time, observed after transplantation of bone marrow-derived mesenchymal stromal cells (29, 30, 33, 45) and alveolar we observed persistence of transplanted cells by PCR amplification of specific allogeneic or xenogeneic donor type II epithelial cells (36).
We have previously demonstrated that hAEC, DNA sequences, as well as by immunohistochemistry.
In a previous study, we have demonstrated engraftment hAMSC, and hCMSC obtained from fetal membranes of human term placenta contain a variety of stem cells that of human placenta-derived cells in various organs, including lung, at day 90 after xenogeneic intraperitoneal display high plasticity and low immunogenicity in vitro (25, 32) . We have also shown that, after intraperitoneal transplantation (1). However, microchimerism was detectable only by PCR in those studies, suggesting that transplantation, these cells can engraft into different organs including bone marrow, thymus, brain, and lung out of the cells present at day 14 after injection, only a relatively small percentage will survive and engraft long (1). In addition, amniotic cells are capable of inhibiting T-cell allogeneic proliferation responses in vitro both in term. Therefore, although questions remain as to whether a direct contact or transwell setting, thereby suggesting that these cells produce soluble factor(s) that could act the beneficial effects on lung fibrosis observed in this study are due to cell engraftment or to transient para-as immunomodulatory agent(s) (25) .
These data are in line with the hypothesis that cells crine actions of the injected cells, the fact we have been able to consistently observe a reduction in lung fibrosis derived from the amniotic membrane have immunomodulatory properties, which has long been supported by by administering both allogeneic or xenogeneic cells via different routes provides convincing proof of the princi-the fact that amniotic membrane has been used as an anti-inflammatory agent in ophthalmology applications ple that placenta-derived cells do indeed confer beneficial effects in bleomycin-induced lung injury. (8) and also explains the effect of these cells on tissue regeneration and reduction of scar formation in animal Even though the severity of inflammation did not show an overall reduction over the time course of this models of spinal cord (34) and myocardial injury (42).
Based on the positive results observed from the appli-study with the different types of cells used, a marked reduction in neutrophil infiltration was observed both cation of bone marrow-derived mesenchymal stromal cells in lung fibrosis (30) , as well as the immunomodu-after xeno-and allotransplantation.
The mechanism by which placenta-derived cells latory/anti-inflammatory characteristics that have been reported for placenta-derived cells (32), we set out to might affect infiltration by neutrophils remains to be elucidated. However, our observations are in accordance test the effects of transplanting amniochorionic membrane cells into a mouse model of bleomycin-induced with the finding that transplantation of bone marrow MSC into the injured lung of mice results in a dramatic lung fibrosis. We designed both xenogeneic and allogeneic transplantation models in order to avoid potential decrease in neutrophil levels in the bronchoalveolar lavage (BAL) samples (29) . A reduction in neutrophil lev-limitations in cell interactions, which may have been caused by interspecies differences. els after syngeneic MSC transplantation has also been observed in the BAL of mice in which lung injury was In previous studies, either local (intratracheal) (13,36) or systemic (intrajugular) (26, 29, 30) routes of cell deliv-induced by lipopolysaccharide (26) . Therefore, the reduction in the levels of neutrophils ery have been used. Given that the large size of human placenta-derived cells frequently resulted in occlusion of that we observed may be partly responsible for the con-
